跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AGRYLIN anagrelide (as hydrochloride) 0.5mg capsule bottle - TGA Drug Approval Details
Approvals
/
TGA
/
AGRYLIN anagrelide (as hydrochloride) 0.5mg capsule bottle
Approved
STANDARD
AGRYLIN anagrelide (as hydrochloride) 0.5mg capsule bottle
Takeda Pharmaceuticals Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e87fda3f0bac7b39
Company
Takeda Pharmaceuticals Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e87fda3f0bac7b39
Product Name
AGRYLIN anagrelide (as hydrochloride) 0.5mg capsule bottle
Artg Id
71752
Artg Name
AGRYLIN anagrelide (as hydrochloride) 0.5mg capsule bottle
Sponsor
Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path
/organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date
2000-02-16
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f326b6bd2cf73e97814e8f079b0b324a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/342147533e9a006b2c94f90a1fa97b84.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e87fda3f0bac7b39
Type
Standard
Back to TGA Approvals